ArticleFrontiers in genetics2018

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.

Federica Baldassari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.